Fundraising FoxLigandal
5 known investors
Find your way into Ligandal
Each arrow is one introduction. Sign up to fill in the first one.
Ask Matt McCambridge to introduce you to Andre Watson
You →Matt · together at Forbes 30 Under 30 2021 · Healthcare →Andre
Sign up to find every way you can get introduced to Ligandal
- Your email: who you already know at Ligandal, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ligandal team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ligandal develops precision medicine targeting technology, including its Peptide Direct Conjugate (PDC) platform driven by LigandAI and Predictive Interactomics, to guide therapeutics to specific disease sites at the molecular level. The company positions its technology as an enabling delivery layer for next-generation, molecularly and genomically precise therapeutics.
Founders & leadership
Investors · 5
How we know: the VCSheet dataset · Not right? Tell us
How we know: Hemisphere Ventures LLC's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Ligandal do?
- Ligandal develops precision medicine targeting technology, including its Peptide Direct Conjugate (PDC) platform driven by LigandAI and Predictive Interactomics, to guide therapeutics to specific disease sites at the molecular level. The company positions its technology as an enabling delivery layer for next-generation, molecularly and genomically precise therapeutics.
- Who founded Ligandal?
- Ligandal was founded by Andre Watson.
- Who are Ligandal's investors?
- Ligandal's investors include Flucas Ventures, Hemisphere Ventures LLC, Machina Ventures, Sommet AB, Learn Capital.